A Novel Approach for Minimizing Immortal Time Bias in Observational Studies
Speaker(s)
Kiri V1, Messina P2, Knight T3
1Labcorp Clinical Development, Ltd., Guildford, SRY, UK, 2Labcorp Clinical Development, Ltd., Milan, SRY, Italy, 3Labcorp Clinical Development Inc., Gaithersburg, MD, USA
Presentation Documents
OBJECTIVES: To describe a novel and innovative approach that uses propensity scores to minimize immortal time bias.
METHODS: Immortal time arises when the determination of a patient’s treatment status involves a waiting period. A bias is introduced when this period is unaccounted for in the assessment of treatment effectiveness and/or safety. We classified treatment status at cohort entry (ie, time=t0) based on whether or not the patient initiated treatment at any time during the study period, with actual treatment initiation time as t1 (ie, t1≥t0). We simulated data for multiple scenarios with fixed treatment effects in three hazard ratio (HR) settings (HR=0.5, 1, and 3), that included the following variables (with varying values): waiting period (1-24 months), proportion of treated patients (10-50%), and two independent covariates. We derived two sets of propensity scores on each patient. Firstly, PS0 at t0 to construct blocks of comparable patients. For each treated patient, the closest untreated patient on PS0 among those who survived up to t1 was selected by 1:1 greedy matching. Secondly, with t1 as start of follow-up for the treated and untreated patients in that block, we derived PS1 and used inverse probability treatment weighting (IPTW) to address confounding. The percentages of residual bias were compared to those from three approaches: unadjusted (crude), landmark with IPTW (LMK), and time-dependent Cox with covariates adjustment (TDC).
RESULTS: Our approach yielded the lowest median percentage of residual bias across all scenarios (HR=0.5: 2.8% vs 82.4% for crude, 12.4% for LMK, 10.6% for TDC; HR=1: 4.0% vs 83.2% for crude, 4.6% for LMK, 12.1% for TDC; HR=3: 4.2% vs 73.7% for crude, 36.7% for LMK, 14.8% for TDC).
CONCLUSIONS: Our results suggest that the propensity score is an effective design tool for minimizing immortal time bias.
Code
MSR3
Topic
Clinical Outcomes, Epidemiology & Public Health, Methodological & Statistical Research
Topic Subcategory
Clinical Outcomes Assessment, Comparative Effectiveness or Efficacy, Confounding, Selection Bias Correction, Causal Inference, Safety & Pharmacoepidemiology
Disease
No Additional Disease & Conditions/Specialized Treatment Areas